No Data
Express News | The largest increase in margin balance this week: TaxFriend's margin balance: 0.028 billion yuan, balance increase: 222.96%; Rendo Biotechnology's margin balance: 0.04 billion yuan, balance increase: 142.4%
Third Quarter Report 2024
RenDu Biology (688193.SH) plans to distribute 1 yuan for every 10 shares at the interim dividends, with ex-rights and ex-dividends on October 30th.
Announcement from Rendo Biotech (688193.SH), the company plans to distribute a cash dividend of 1 per 10 shares for the first half of 2024...
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Rendu Biology (688193.SH): net income of 43.308 million yuan in the first half of the year, turning losses into profits year-on-year.
RenDu Bio (688193.SH) disclosed its semi-annual report for 2024, with the company achieving a revenue of 86.6802 million yuan for the reporting period, an increase of 8.31% year-on-year. The net income attributable to shareholders of the listed company was 4.3308 million yuan, turning losses into profits year-on-year. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.1434 million yuan. The basic earnings per share is 0.12 yuan/share. The company plans to distribute a cash dividend of 1.00 yuan (tax included) for every 10 shares.
No Data
No Data